3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
29
Brain Neoplasms
28
Prostatic Neoplasms
27
Neoplasm Metastasis
18
Lung Neoplasms
18
Breast Neoplasms
13
Melanoma
12
Carcinoma, Renal Cell
8
Pancreatic Neoplasms
7
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
5
Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
NSCLC
3
Meningioma
3
Hematologic Neoplasms
3
Gastrointestinal Neoplasms
3
Uveal Melanoma
2
Unresectable Locally Recurrent Rectal Cancer
2
Thyroid Neoplasms
2
Spinal Cord Compression
2
Sarcoma
2
Head and Neck Neoplasms
2
Epidural Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Merkel Cell
2
Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Interventions
pasireotide
1
lutetium Lu 177 dotatate
1
lanreotide
1
amino-acid, glucose, and electrolyte solution
1
Sunitinib
1
Octreotide
1
Everolimus
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Radiosurgery
×
90 days
×
Clear all
No trials found.